Results 51 to 60 of about 894,811 (216)

A risk score for pericarditis recurrence

open access: yesEuropean Journal of Clinical Investigation, 2021
AbstractBackgroundCurrently, we remain uncertain about which patients are at increased risk for recurrent pericarditis. We developed a risk score for pericarditis recurrence in patients with acute pericarditis.Materials and methodsWe prospectively recruited 262 patients with a first episode of acute pericarditis.
Emilia Lazarou   +10 more
openaire   +4 more sources

Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome

open access: yesBMC Cardiovascular Disorders, 2019
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy ...
Leon L. Lutschinger   +6 more
doaj   +1 more source

Acute and Recurrent Pericarditis

open access: yesCardiology Clinics, 2017
Acute and recurrent pericarditis is the most common pericardial syndrome encountered in clinical practice either as an isolated process or as part of a systemic disease. The diagnosis is based on clinical evaluation, electrocardiogram, and echocardiography.
Imazio M, Gaita F
openaire   +4 more sources

Recurrent pericarditis after Covid-19

open access: yesReumatología Clínica (English Edition), 2022
Patient with rheumatoid arthritis who has Covid-19 with recurrent pericaditis debut, differential diagnosis.
Rodrigo Domínguez, David   +5 more
openaire   +3 more sources

Expanding the Patient Pool for Rilonacept

open access: yesJACC: Case Reports
Recurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD   +9 more
doaj   +1 more source

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis

open access: yesReviews in Cardiovascular Medicine, 2023
Acute pericarditis is the most frequent pericardial disease characterized by inflammation of the pericardial layers resulting in pain, dyspnea and fatigue.
Aldo Bonaventura   +8 more
doaj   +1 more source

Recurrent Pericarditis [PDF]

open access: yesCirculation, 2005
Recurrence is a serious complication of acute pericarditis, characterized by a return of pericardial pain after recovery from an attack of typical acute pericarditis. Some patients experience only a single recurrence, but in many less fortunate, pericardial pain returns unexpectedly at variable intervals during a period that may extend over many years.
openaire   +1 more source

Idiopathic recurrent pericarditis — a paradigm shift?

open access: yesРоссийский кардиологический журнал, 2019
Idiopathic recurrent  pericarditis (IRP) is a relatively rare inflammatory disease of the pericardium,  often  requiring  emergency medical  care,   associated with a  high percentage of temporary  disability and  significant  economic  costs.
V. Yu. Myachikova   +3 more
doaj   +1 more source

Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype.

open access: yesEuropean journal of internal medicine
BACKGROUND Differences in recurrent pericarditis with normal vs. elevated C-reactive protein (CRP) are unknown. MATERIALS AND METHODS We studied 448 patients with recurrent or incessant pericarditis. CRP levels
R. Mascolo   +15 more
semanticscholar   +1 more source

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2022
Background: Vaccines against SARS-COV2 have been crucial in efforts against COVID19, yet there have been reports of pericarditis following vaccination with mRNA-based vaccines.
Yishay Wasserstrum   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy